The global filtration market is estimated to grow from USD 6.5 billion in the current year to USD 15 billion by 2035, at a CAGR of 8.71% during the forecast period, till 2035.
Biopharmaceutical filtration involves the purification and sterilization of biological drug products without the utilization of heat or chemicals. A notable development in this sector has been the implementation of innovative filtration systems, including depth filtration, tangential flow filtration, virus filtration, and chromatography filtration systems. These systems can be utilized across numerous applications owing to their adaptable characteristics. Numerous pharmaceutical firms have already invested in advanced technologies to enhance their traditional filtration methods. The main focus of implementing these filters is to secure the maximum purity and yield of the intended biological product while ensuring its safety and efficacy for human or animal health applications. Due to continuous improvements in biologics, various companies have created and introduced their own biopharmaceutical filtration systems for enhanced purification of biologics. In this context, the expansion of the global filtration market is anticipated to be fueled by the increasing demand for biologics in the coming years.
Filtration Market
FILTRATION MARKET: GROWTH AND TRENDS
Biologics is one of the fastest expanding segments within the healthcare industry. In the past five years, more than 75 biologics have received approval from USFDA, with nearly 10,000 biologics undergoing evaluation at various development stages. This increasing demand for biologics has resulted in the necessity for creating advanced technologies for the purification these drug substances. This requirement is primarily influenced by the sensitivity of biologics to heat and other chemical purification methods, which can lead to the deterioration of the end product.Biopharmaceutical filtration involves the purification and sterilization of biological drug products without the utilization of heat or chemicals. A notable development in this sector has been the implementation of innovative filtration systems, including depth filtration, tangential flow filtration, virus filtration, and chromatography filtration systems. These systems can be utilized across numerous applications owing to their adaptable characteristics. Numerous pharmaceutical firms have already invested in advanced technologies to enhance their traditional filtration methods. The main focus of implementing these filters is to secure the maximum purity and yield of the intended biological product while ensuring its safety and efficacy for human or animal health applications. Due to continuous improvements in biologics, various companies have created and introduced their own biopharmaceutical filtration systems for enhanced purification of biologics. In this context, the expansion of the global filtration market is anticipated to be fueled by the increasing demand for biologics in the coming years.
FILTRATION MARKET: KEY INSIGHTS
The report delves into the current state of the filtration market and identifies potential growth opportunities within industry. Some key findings from the report include:
- Presently, close to 85 players are offering biopharmaceutical filtration systems across the globe; of these, over 80% companies claim to have the capability to develop membrane filters for a wide range of application areas.
- The biopharmaceutical filtration systems market is primarily characterized by the presence of well-established players; of these, over 75% firms develop systems for cell separation and product purification.
- In pursuit of gaining a competitive edge, stakeholders are actively upgrading existing capabilities and enhancing their respective offerings to comply with the evolving industry benchmarks.
- Both industry and non-industry players have participated in various global events to demonstrate the ongoing research outcomes, affiliated challenges, as well as opportunities in the biopharmaceutical filtration industry.
- In the last five years, more than 125 patents related to biopharmaceutical filtration have been granted to various industry and non-industry stakeholders.
- Given the rising demand for biologics, stakeholders are actively establishing themselves as one-stop-shops, by consolidating their capabilities, related to biopharmaceutical filtration, via mergers and acquisitions.
- The biopharmaceutical filtration market is projected to grow at a CAGR of 8.71%, till 2035; the forecasted opportunity is likely to be distributed across different types of filtration systems and filter assemblies.
- In the long-term, majority share of the revenues is likely to be generated from single-use technologies; North America is anticipated to capture a relatively larger proportion of the overall market, by 2035.
FILTRATION MARKET: KEY SEGMENTS
Membrane Filtration to Drive the Market Growth over the Forecast Period
Owing to the swift expansion of the biopharmaceutical sector and the rise in research and development efforts, the potential opportunities and growth linked to the filtration market for biologics are expected to drive significant growth in the upcoming future. Based on the type of filter, the market is expected to be propelled by membrane filtration systems, followed by depth filtration systems and tangential flow filtration systems. The membrane filtration market is expected to expand at a CAGR of 7% throughout the anticipated period. Additionally, it is anticipated that over 60% of the market will be comprised of companies located in North America and Europe in the coming future.Example Players in the Filtration Market
- Alfa Laval
- Asahi Kasei
- Cobetter Filtration
- Corning
- Merck KGaA
- Pall Corporation (a company of Danaher Corporation)
- Parker Hannifin
- Sartorius
- Thermo Fisher Scientific
FILTRATION MARKET: RESEARCH COVERAGE
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the filtration market, focusing on key market segments, including [A] type of filter system / element, [B] type of filter, [C] type of assembly, [D] company size, [E] key geographical regions.
- Market Landscape: A detailed assessment of companies offering biopharmaceutical filtration systems based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of filter system / element and application area(s). In addition, companies have also been evaluated on the basis on [E] type of filter, [F] type of filter module, [G] type of media material, [H] type of assembly, [I] novel filtration systems and [J] type of technique(s) used.
- Company Competitiveness Analysis: A comprehensive competitive analysis of biopharmaceutical filtration system manufacturers across North America, Europe and Asia-Pacific, examining factors, such as [A] supplier strength [B] product strength and [C] application area.
- Company Profiles: In-depth profiles of prominent players engaged in this domain, that are currently involved in filtration market, focusing on [A] year of establishment, [B] location of headquarters, [C] product portfolio, [D] recent developments and [E] an informed future outlook.
- Recent Developments: An insightful analysis of the recent developments / trends in the biopharmaceutical filtration market, offering insights on patents that have been filed / granted for biopharmaceutical filters, since 2019, based on relevant parameters, such [A] patent publication year, [B] patent jurisdiction, [C] CPC symbols, [D] emerging focus areas, [E] leading players, [F] patent benchmarking, [G] patent characteristics and [H] patent age. In addition, it provides information on recent mergers and acquisitions reported in global filtration market, including details on [I] year, [J] deal amount, [K] regional distribution and [L] key players.
- Global Event Analysis: A comprehensive examination of global events that took place in the global filtration market, since 2018 based on several relevant parameters, such as [A] year of event, [B] event platform, [C] type of event, [D] geography, [E] type of filter, [F] type of filter system involved, [G] type of process involved, [H] most active and [I] application area.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- What is the current global capacity of developers?
- What factors are likely to influence the evolution of this market?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with the Research Team
- Free Update if the Report is 6+ Months Old
Table of Contents
1. PREFACE
3. INTRODUCTION
4. MARKET LANDSCAPE: BIOPHARMACEUTICAL FILTRATION
5. COMPANY COMPETITIVENESS ANALYSIS
6. BIOPHARMACEUTICAL FILTRATION SYSTEM SUPPLIERS IN NORTH AMERICA
7. BIOPHARMACEUTICAL FILTRATION SYSTEM SUPPLIERS IN EUROPE AND ASIA-PACIFIC
8. RECENT DEVELOPMENTS
9. GLOBAL EVENTS ANALYSIS
10. MARKET FORECAST
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M
- 4th Phase Water Technologies
- ABEC
- Agilitech
- Alfa Laval
- Almirall
- Amazon Filters
- American Filtration & Separations Society (AFS)
- Amgen
- Artemis Biosystems
- ARTeSYN Biosolutions (Acquired by Repligen)
- Asahi Kasei
- Automated Engineering Services
- BEA Technologies
- Becton Dickinson
- Bio - Link
- BioCon Solutions
- BIONET
- Bionova Scientific (Acquired by Asahi Kasei)
- Biotree
- Cambridge Healthtech Institute
- Cobetter Filtration
- Cole - Parmer (Acquired by Antylia Scientific)
- Corning
- Critical Process Filtration
- Cytiva
- Danaher
- Donaldson
- DrM
- Eaton
- Entegris
- ErtelAlsop
- Filtravate
- FILTROX
- GE Heathcare (Acquired by Danaher)
- GEA
- Genzyme (Acquired by Sanofi)
- GeShi Fluid (Acquired by LePure Biotech)
- Global Filter
- Gopani Product Systems
- Gore PharmBIO Products
- GPC Bio
- Graver Technologies
- Guochu Technology
- GVS
- Hangzhou Deefine Filtration Technology
- Hangzhou Guidling Technology
- Hangzhou Anow Microfiltration (Acquired by Entegris)
- Helapet
- Hollingsworth & Vose
- Hongtek Filtration
- INDA
- InnovaPrep
- International Filter Products
- International Flavors & Fragrances
- Isolere Bio (Acquired by Donaldson)
- Koch Separation Solutions
- LePure Biotech
- Lisure Science
- mdi Membrane Technologies
- Meissner Filtration Products
- Membrane Solutions
- Merck
- Metso Outotec
- Microfilt
- MMS Membrane Systems
- Murata Manufacturing
- Nantong FilterBio Membrane
- Napro Scientific
- Novasep
- Nupore Filtration Systems
- Pacira Pharmaceuticals (a subsidiary of Pacira Biosciences)
- Pall Corporation (Acquired by Danaher)
- Pall-Austar Lifesciences (Acquired by Pall Corporation)
- Parker Hannifin
- Perfect Group
- Phenomenex
- Porvair Filtration
- RephiLe Bioscience
- Repligen
- Rocker Scientific
- SABEU
- Saint-Gobain
- SANI Membranes
- Sartorius
- Schneider Electric
- Sentinel Process Systems
- Serene Filter Solution
- Simsii
- SmartfFow Technologies
- Solaris Biotech (Acquired by Donaldson)
- Spectrum Pharmaceuticals (Acquired by Repligen)
- Sterlitech
- Synder Filtration
- Sysbiotech
- TAMI Industries
- TangenX (Acquired by Repligen)
- Technofilter
- The Strainrite Companies
- Thermo Fisher Scientific
- TPP Techno Plastic Products
- Trinity Filtration Technologies
- VyCAP
- WaterSep BioSeparations (Acquired by Sartorius)
- Wisconsin Alumni Research Foundation
- YMC America
- Zhejiang ALWSCI Technologies
- Zista Education
Methodology
LOADING...
